Walleye Trading’s Nuvalent NUVL Stock Holding History

Walleye Trading’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,944	Closed	-$290K	–	5149
2023 Q4	$290K	Sell	3,944 -3,019	-43%	-$187K	﹤0.01%	3516
2023 Q3	$320K	Buy	+6,963	New	+$309K	﹤0.01%	3315

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Walleye Trading's NUVL Position: Q1 2024 in Review

Walleye Trading sold out of Nuvalent (NUVL) in Q1 2024, closing a stake of 3,944 shares — an estimated $290K sold.

Walleye Trading first reported a position in NUVL in Q3 2023 and held it in 2 quarters. The position peaked at $320K in Q3 2023. 180 funds tracked by Wall St. Rank hold NUVL as of Q1 2024.

Walleye Trading reported no remaining Nuvalent position as of Q1 2024 after selling out during the quarter.
Walleye Trading sold 3,944 Nuvalent shares in Q1 2024, an estimated $290K.
Walleye Trading first reported a position in Nuvalent in Q3 2023 and held it in 2 quarters.
Walleye Trading's Nuvalent position peaked at $320K in Q3 2023.
180 funds tracked by Wall St. Rank held Nuvalent as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.